APA (7th ed.) Citation

Motsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., . . . Paschke, A. (2020). RESTORE-IMI 1: A multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections. Clinical infectious diseases, 70(9), . https://doi.org/10.1093/cid/ciz530

Chicago Style (17th ed.) Citation

Motsch, Johann, et al. "RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/relebactam Vs Colistin Plus Imipenem in Patients with Imipenem-nonsusceptible Bacterial Infections." Clinical Infectious Diseases 70, no. 9 (2020). https://doi.org/10.1093/cid/ciz530.

MLA (9th ed.) Citation

Motsch, Johann, et al. "RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/relebactam Vs Colistin Plus Imipenem in Patients with Imipenem-nonsusceptible Bacterial Infections." Clinical Infectious Diseases, vol. 70, no. 9, 2020, https://doi.org/10.1093/cid/ciz530.